Effect of Tocopheryl Polyethylene Glycol Succinate on the Percutaneous Penetration of Minoxidil from Water/Ethanol/Polyethylene Glycol 400 Solutions
暂无分享,去创建一个
M. Sheu | H. Ho | A. Wu | Keng-Ping Lin | C. Shen
[1] Lawrence X. Yu,et al. Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing Its Solubility and Permeability1 , 1999, Pharmaceutical Research.
[2] Ling-chun Chen,et al. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[3] D. West,et al. Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients. , 2000, Contact dermatitis.
[4] N. Weiner,et al. Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion. , 1995, Journal of pharmaceutical sciences.
[5] N. Weiner,et al. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin. , 1994, Journal of pharmaceutical sciences.
[6] F. Suchy,et al. Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. , 1993, Gastroenterology.
[7] N. Weiner,et al. Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions. , 1992, Journal of pharmaceutical sciences.
[8] S. E. Whitmore. The importance of proper vehicle selection in the detection of minoxidil sensitivity. , 1992, Archives of dermatology.
[9] M. Traber,et al. Uptake of intact TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) a water-miscible form of vitamin E by human cells in vitro. , 1988, The American journal of clinical nutrition.
[10] V. Fiedler‐Weiss. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. , 1987, Journal of the American Academy of Dermatology.
[11] K. C. James,et al. Solubility and Related Properties , 1986 .
[12] S. Veronesi,et al. Contact dermatitis to Minoxidil , 1985, Contact dermatitis.
[13] T. Franz. Percutaneous absorption of minoxidil in man. , 1985, Archives of dermatology.
[14] Vilches Ar,et al. Case 32-1980: minimal-change disease with mesangial IgM deposits. , 1980 .
[15] Zappacosta Ar,et al. Reversal of baldness in patient receiving minoxidil for hypertension. , 1980 .
[16] J. Burton,et al. Hypertrichosis due to minoxidil , 1979, The British journal of dermatology.
[17] G. Dunea,et al. Severe hypertension. Treatment with minoxidil. , 1975, JAMA.